Migraine: features of the principally of treatment
ARTICLE PDF (Українська)


headache, migraine, treatment of migraine

How to Cite

Svystun, V., Cherednichenko, T., Drigant, L., Parnikosa, T., Sereda, V., & Khanenko, N. (2016). Migraine: features of the principally of treatment. East European Journal of Neurology, (2(8), 4-8. https://doi.org/10.33444/2411-5797.2016.2(8).4-8


The questions of relevance, the prevalence of migraine are recommendations for the treatment of migraine, founded on the principles of evidence-based medicine. The effectiveness of the recommended therapies, including the use of triptans, confirmed by large placebo-controlled trials. Due to the fact that the number of patients with migraine growing diagnosis of migraine attacks, treatment selection, in accordance with international recommendations will help facilitate this type of headache.

ARTICLE PDF (Українська)


1. Michael J. Marmura MD. The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies / Michael J. Marmura MD, Stephen D. Silberstein MD, FACP,Todd J. Schwedt MD, MSCI // Headache The journal of Head and Face Pain. - 2015. - № 55(1). - P. 3-20.
2. Nouchine Hadjikhani, MD. The relevance of cortical thickness in migraine sufferers / Nouchine Hadjikhani, MD // Expert Review of Neurotherapeutics. - 2008. - № 8(3). P. - 327-329.
3. Todd A. Smitherman, PhD. The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies / Todd A. Smitherman PhD, Rebecca Burch MD, Huma Sheikh MD, Elizabeth Loder MD, MPH // - 2013. - №53(3). - P 427-436.
4. Benjamin Gilmore, MD. Treatment of Acute Migraine Headache / Benjamin Gilmore, MD, Magdalena Michael, MD // American Family Physician. - 2011. - № 83(3). - P. 271-280.
5. Wells R.E., Turner D.P., Lee M., Bishop L., Strauss L. Managing Migraine During Pregnancy and Lactation//Curr. Neurol. Neurosci Rep. 2016 Apr;16(4):40.
6. Lainez M.J., Galvan J., Heras J., Vila C. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy // Eur. J. Neurol. – 2007. – Vol. 14. – P. 269–275.
7. Hall G., Brown M., Mo J., MacRae K.D. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice // Neurology. – 2004. – Vol. 62. – P. 563–568.
8. Charlesworth B.R., Dowson A.J., Purdy A. et al. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomized, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet // CNS Drugs. – 2003. – Vol. 17. – P. 653–667.
9. Dahlof C., Cady R., Poole A.C. Speed of onset and efficacy of sumatriptan fast disintegrating/rapid release tablets: results of two replicate randomized, placebo-controlled studies // Headache Care. – 2004. – Vol. 1. – P. 277–280.
10. Tepper S.J., Chen S., Reidenbach F., Rapoport A.M. Intranasal zolmitriptan for the treatment of acute migraine // Headache. – 2013. – Vol. 53 (Suppl. 2). – P. 62–71.
11. Свиридова Н.К. Особенности диагностики и лечения головной боли, связанной с приступами мигрени / Свиридова Н.К. // Східно-європейський неврологічний журнал. - 2015. – № 1. – С. 8-12.